Post-trial access to treatment: corporate best practices

SOMO Centre for Research on Multinational Corporations (2015)
Download Edit this record How to cite View on PhilPapers
Abstract
The paper Post-Trial Acces To Treatment (PTA) offers an insight into current corporate policies and corporate best practices relating to the provision of PTA in low and middle income countries based on company sources. In these countries there is a greater appeal for pharmaceutical companies to take responsibility for providing PTA. However, the practice of providing PTA is the exception rather than the rule.
PhilPapers/Archive ID
COLPAT-9
Upload history
Archival date: 2015-03-03
View other versions
Added to PP index
2015-03-03

Total views
134 ( #29,057 of 51,740 )

Recent downloads (6 months)
18 ( #29,795 of 51,740 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.